Latest news
Earnings Preview: LEGN to Report Financial Results Pre-market on August 11 - MoomooMoomoo · Thu, 06 Aug 2026 01:00:27 GMTRBC Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Cuts Target Price to $59 - MoomooMoomoo · Mon, 27 Jul 2026 19:11:39 GMTRBC Cuts Price Target on Legend Biotech to $59 From $63, Keeps Outperform Rating - MoomooMoomoo · Mon, 27 Jul 2026 14:54:22 GMTLegend Biotech Shares Down 3.7% Premarket; Yi - MoomooMoomoo · Mon, 27 Jul 2026 10:21:54 GMTLegend Biotech CEO Ying Huang Resigns - MoomooMoomoo · Mon, 27 Jul 2026 07:00:00 GMTLegend Biotech's In Vivo CAR-T Cell Therapy Data Validates Approach, RBC Capital Markets Says - MoomooMoomoo · Mon, 27 Jul 2026 07:00:00 GMT